TRIL - トリリウム・セラピュ―ティクス (Trillium Therapeutics Inc.)

TRILのニュース

   Trillium Therapeutics' CD47 Assets Show Continued Anti-Tumor Activity In Hematologic Malignancies  2021/04/28 13:11:22 Benzinga
Trillium Therapeutics Inc (NASDAQ: TRIL ) has provided a data update for TTI-622 and 621 programs in hematologic malignancies. As of cut-off data April 12, TTI-622 monotherapy shows a 33% objective response rate (ORR) in relapsed/refractory (R/R) lymphomas at 0.8-18 mg/kg doses, including three new responses (1 Complete Response (CR) + 2 Partial Responses (PRs)) since last data disclosure at the American Society of Hematology 2020 … Full story available on Benzinga.com
   Thinking about buying stock in IsoRay, Trillium Therapeutics, Plug Power, Baudax Bio, or Aslan Pharmaceuticals?  2021/03/17 13:31:00 PR Newswire
NEW YORK, March 17, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ISR, TRIL, PLUG, BXRX, and ASLN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Trillium Therapeutics Factors Likely to Have Influenced Earnings Results Stock market Insights & financial analysis  2021/03/16 03:19:00 Stock Market Daily
Trillium Therapeutics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Trillium Therapeutics Inc. (NASDAQ:TRIL) Insider Penka Petrova Sells 5,312 Shares  2021/03/13 14:20:44 Watchlist News
Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSE:TR) insider Penka Petrova sold 5,312 shares of the firm’s stock in a transaction dated Wednesday, March 10th. The shares were sold at an average price of $11.08, for a total value of $58,856.96. Following the completion of the transaction, the insider now owns 2,708 shares in the company, valued at […]
   Warren Buffett: His Advice on Market Crashes  2021/03/04 19:45:58 The Motley Fool Canada
Warren Buffett generously shares his insights to guide investors prepare for a market crash. He also has a bright outlook for the healthcare sector. In the TSX, Trillium Therapeutics stock is poised to deliver superior gains with two lead drug candidates. The post Warren Buffett: His Advice on Market Crashes appeared first on The Motley Fool Canada .
   Trillium Therapeutics' CD47 Assets Show Continued Anti-Tumor Activity In Hematologic Malignancies  2021/04/28 13:11:22 Benzinga
Trillium Therapeutics Inc (NASDAQ: TRIL ) has provided a data update for TTI-622 and 621 programs in hematologic malignancies. As of cut-off data April 12, TTI-622 monotherapy shows a 33% objective response rate (ORR) in relapsed/refractory (R/R) lymphomas at 0.8-18 mg/kg doses, including three new responses (1 Complete Response (CR) + 2 Partial Responses (PRs)) since last data disclosure at the American Society of Hematology 2020 … Full story available on Benzinga.com
   Thinking about buying stock in IsoRay, Trillium Therapeutics, Plug Power, Baudax Bio, or Aslan Pharmaceuticals?  2021/03/17 13:31:00 PR Newswire
NEW YORK, March 17, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ISR, TRIL, PLUG, BXRX, and ASLN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Trillium Therapeutics Factors Likely to Have Influenced Earnings Results Stock market Insights & financial analysis  2021/03/16 03:19:00 Stock Market Daily
Trillium Therapeutics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Trillium Therapeutics Inc. (NASDAQ:TRIL) Insider Penka Petrova Sells 5,312 Shares  2021/03/13 14:20:44 Watchlist News
Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSE:TR) insider Penka Petrova sold 5,312 shares of the firm’s stock in a transaction dated Wednesday, March 10th. The shares were sold at an average price of $11.08, for a total value of $58,856.96. Following the completion of the transaction, the insider now owns 2,708 shares in the company, valued at […]
   Warren Buffett: His Advice on Market Crashes  2021/03/04 19:45:58 The Motley Fool Canada
Warren Buffett generously shares his insights to guide investors prepare for a market crash. He also has a bright outlook for the healthcare sector. In the TSX, Trillium Therapeutics stock is poised to deliver superior gains with two lead drug candidates. The post Warren Buffett: His Advice on Market Crashes appeared first on The Motley Fool Canada .
   Thinking about buying stock in IsoRay, Trillium Therapeutics, Plug Power, Baudax Bio, or Aslan Pharmaceuticals?  2021/03/17 13:31:00 PR Newswire
NEW YORK, March 17, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ISR, TRIL, PLUG, BXRX, and ASLN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Trillium Therapeutics Factors Likely to Have Influenced Earnings Results Stock market Insights & financial analysis  2021/03/16 03:19:00 Stock Market Daily
Trillium Therapeutics announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Trillium Therapeutics Inc. (NASDAQ:TRIL) Insider Penka Petrova Sells 5,312 Shares  2021/03/13 14:20:44 Watchlist News
Trillium Therapeutics Inc. (NASDAQ:TRIL) (TSE:TR) insider Penka Petrova sold 5,312 shares of the firm’s stock in a transaction dated Wednesday, March 10th. The shares were sold at an average price of $11.08, for a total value of $58,856.96. Following the completion of the transaction, the insider now owns 2,708 shares in the company, valued at […]
   Warren Buffett: His Advice on Market Crashes  2021/03/04 19:45:58 The Motley Fool Canada
Warren Buffett generously shares his insights to guide investors prepare for a market crash. He also has a bright outlook for the healthcare sector. In the TSX, Trillium Therapeutics stock is poised to deliver superior gains with two lead drug candidates. The post Warren Buffett: His Advice on Market Crashes appeared first on The Motley Fool Canada .
   Canada's CDPQ in talks to buy Durg Bypass project from Tata Sons arm  2021/01/31 20:56:00 Economic Times India
One of the multiple people aware of the talks told ET that CDPQ has already signed a term sheet for buying the operational asset of Tata Realty and Infrastructure Limited (TRIL).

calendar